Harrow Health, Inc. (HROW) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
102 WOODMONT BLVD NASHVILLE, TN 37215 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 5,839 | 42,167 | 4,101 | 250 | 250 | 4,019 | |||
| Cash and cash equivalents | 250 | 42,167 | 4,101 | 250 | 250 | 4,019 | |||
| Short-term investments | 5,589 | ||||||||
| Restricted cash and investments | 200 | ||||||||
| Receivables | 6,249 | 4,470 | 2,662 | 2,009 | 1,964 | 1,624 | |||
| Inventory, net of allowances, customer advances and progress billings | 6,541 | 4,217 | 3,962 | 3,301 | 1,834 | 2,249 | |||
| Inventory | 6,541 | 4,217 | 3,962 | 3,301 | 1,834 | 2,249 | |||
| Prepaid expense | 3,354 | 1,165 | 561 | 481 | 662 | 590 | |||
| Asset, held-for-sale, not part of disposal group | 512 | ||||||||
| Other current assets | 118 | 92 | 190 | 105 | 125 | 124 | |||
| Other undisclosed current assets | 96,159 | 8,551 | 28,655 | 30,621 | 27,496 | ||||
| Total current assets: | 118,260 | 60,662 | 40,131 | 36,767 | 32,843 | 8,806 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 7,513 | 5,935 | 6,799 | 6,559 | ✕ | ✕ | |||
| Property, plant and equipment | 3,486 | 3,141 | 4,453 | 5,375 | 6,375 | 6,215 | |||
| Long-term investments and receivables | 302 | ||||||||
| Accounts and financing receivable, after allowance for credit loss | 302 | ||||||||
| Intangible assets, net (including goodwill) | 24,057 | 16,145 | 2,271 | 2,669 | 5,286 | 5,087 | |||
| Goodwill | 332 | 332 | 332 | 332 | 2,227 | 2,227 | |||
| Intangible assets, net (excluding goodwill) | 23,725 | 15,813 | 1,939 | 2,337 | 3,059 | 2,860 | |||
| Other undisclosed noncurrent assets | 4,062 | 12,446 | 3,820 | 7,715 | 4,947 | 3,507 | |||
| Total noncurrent assets: | 39,118 | 37,667 | 17,343 | 22,318 | 16,608 | 15,111 | |||
| TOTAL ASSETS: | 157,378 | 98,329 | 57,474 | 59,085 | 49,451 | 23,917 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 13,771 | 6,337 | 3,932 | 7,702 | 6,250 | 3,885 | |||
| Interest and dividends payable | ✕ | ✕ | 28,034 | 2,927 | (7,459) | ||||
| Employee-related liabilities | ✕ | ✕ | 3,089 | 2,315 | 2,117 | 2,283 | 1,209 | ||
| Accrued liabilities | 45,798 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | (32,027) | (24,786) | (1,310) | 5,585 | 3,967 | 10,135 | |||
| Deferred revenue | 113 | 16 | 66 | 57 | ✕ | ✕ | |||
| Debt | 8 | 3,906 | 2,408 | 3,249 | 598 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 388 | ||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 29 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 119 | ✕ | ||
| Other undisclosed current liabilities | 4,748 | 3,361 | 2,895 | 2,117 | 2,283 | 874 | |||
| Total current liabilities: | 18,632 | 9,722 | 10,799 | 12,284 | 11,901 | 5,774 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 104,174 | 77,676 | 19,047 | 18,583 | 11,999 | 14,728 | |||
| Long-term debt, excluding current maturities | 104,174 | 71,654 | 12,378 | 12,219 | 11,999 | 14,008 | |||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | 720 | |||
| Finance lease, liability | 10 | 17 | 26 | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 7,332 | 800 | 800 | 800 | 800 | ||||
| Accounts payable and accrued liabilities | 800 | 800 | 800 | 800 | |||||
| Operating lease, liability | 7,332 | 6,012 | 6,652 | 6,338 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (6,012) | ||||||||
| Total noncurrent liabilities: | 111,506 | 77,676 | 19,847 | 19,383 | 12,799 | 15,528 | |||
| Total liabilities: | 130,138 | 87,398 | 30,646 | 31,667 | 24,700 | 21,302 | |||
| Equity | |||||||||
| Equity, attributable to parent | 27,595 | 11,286 | 27,183 | 27,711 | 24,751 | 2,615 | |||
| Common stock | 30 | 27 | 26 | 26 | 24 | 21 | |||
| Additional paid in capital | 137,058 | 106,666 | 104,557 | 101,728 | 98,938 | 91,430 | |||
| Accumulated deficit | (109,493) | (95,407) | (77,400) | (74,043) | (74,211) | (88,836) | |||
| Equity, attributable to noncontrolling interest | (355) | (355) | (355) | (293) | |||||
| Total equity: | 27,240 | 10,931 | 26,828 | 27,418 | 24,751 | 2,615 | |||
| TOTAL LIABILITIES AND EQUITY: | 157,378 | 98,329 | 57,474 | 59,085 | 49,451 | 23,917 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 88,595 | 72,476 | 48,871 | 51,165 | 41,372 | 26,774 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 26,774 | |
| Cost of revenue (Cost of Goods and Services Sold) | (25,383) | (18,214) | (14,463) | (16,749) | (16,521) | (13,505) | ||
| Gross profit: | 63,212 | 54,262 | 34,408 | 34,416 | 24,851 | 13,269 | ||
| Operating expenses | (61,293) | (52,648) | (34,023) | (39,219) | (30,068) | (25,432) | ||
| Operating income (loss): | 1,919 | 1,614 | 385 | (4,803) | (5,217) | (12,163) | ||
| Nonoperating income (expense) | (15,930) | (19,488) | (3,800) | 4,678 | 19,842 | (757) | ||
| Investment income, nonoperating | (2,914) | 3,507 | ||||||
| Interest and debt expense | (7,244) | (1) | (2) | (18) | (884) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | (21,255) | (17,875) | (3,417) | (143) | 14,625 | (13,804) | ||
| Other undisclosed income from continuing operations before income taxes | 7,244 | 1 | 2 | 18 | 884 | |||
| Income (loss) from continuing operations before income taxes: | (14,011) | (17,874) | (3,415) | (125) | 14,625 | (12,920) | ||
| Income tax expense (benefit) | (75) | (133) | (4) | (529) | (3,740) | 935 | ||
| Income (loss) from continuing operations: | (14,086) | (18,007) | (3,419) | (654) | 10,885 | (11,985) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (18,007) | (3,419) | (654) | 10,885 | (11,985) | |
| Other undisclosed net income | 529 | |||||||
| Net income (loss): | (14,086) | (18,007) | (3,419) | (125) | 10,885 | (11,985) | ||
| Net income (loss) attributable to noncontrolling interest | 62 | (293) | ||||||
| Other undisclosed net income attributable to parent | 586 | 3,740 | ||||||
| Net income (loss) attributable to parent: | (14,086) | (18,007) | (3,357) | 168 | 14,625 | (11,985) | ||
| Preferred stock dividends and other adjustments | (472) | |||||||
| Net income (loss) available to common stockholders, diluted: | (14,086) | (18,479) | (3,357) | 168 | 14,625 | (11,985) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (14,086) | (18,007) | (3,419) | (125) | 10,885 | (11,985) | ||
| Comprehensive income (loss): | (14,086) | (18,007) | (3,419) | (125) | 10,885 | (11,985) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 62 | (293) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (14,086) | (18,007) | (3,357) | (418) | 10,885 | (11,985) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.